New Foundation Funding
8 minutes ago
1 min read
We have received a generous grant from the Hearst Foundation to support preclinical and IND-enabling studies on our drug candidate for spinal cord injury, TMP-316.
top of page
Recent Posts
See AllOur NCI R01 (Schatz, Ali) received a 1 percentile score. This grant aims to study the essential role of the cyclin-G associated kinase...
The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...
The Ali Lab, in collaboration with the Brambilla lab, received new funding from the State of Florida. The goal of this program is to...
bottom of page
Comments